Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study

Figures & data

Table 1 Sociodemographic data of the study ARD patients according to their decision to receive a booster dose of COVID-19 vaccine (n = 248)

Fig. 1 Classification of ARD patients according to their intention to receive booster dose of COVID-19 vaccine (n = 248)

Table 2 Clinical and therapeutic data of the study ARD patients according to their decision to receive a booster dose of COVID-19 vaccine (n = 248)

Table 3 Vaccine data of the study ARD patients who received COVID-19 vaccine (n = 179)

Fig. 2 Reasons for getting booster dose in acceptant group (n = 79)

Fig. 3 Perception of Health benefits and booster dose acceptance

Fig. 4 Perceived barriers and/or concerns for the booster dose in booster dose hesitant and resistant groups (n = 169)

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.